Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Poyhonen currently holds 48,660 shares of HERON THERAPEUTICS, INC. /DE/ (HRTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Poyhonen has been a net seller of HRTX stock. They have purchased $313.8K and sold $1.4M worth of shares.
John Poyhonen's most recent insider trade was on Apr 13, 2023, when they sold 4,564 shares at $0.00 per share.
John Poyhonen serves as Executive at HERON THERAPEUTICS, INC. /DE/ (HRTX). They have executed 76 insider transactions totaling $1.7M over their tenure at the company.
John Poyhonen holds the position of Executive at HERON THERAPEUTICS, INC. /DE/, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
John Poyhonen has shown a selling trading pattern, with $313.8K in total purchases and $1.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John Poyhonen was on Jun 5, 2014, when they sold $300.8K worth of SNMX shares. This transaction involved 37,600 shares at $8.00 per share.
John Poyhonen currently owns 48,660 shares of HERON THERAPEUTICS, INC. /DE/ (HRTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Poyhonen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Poyhonen has 76 Form 4 filings on record as an insider at HERON THERAPEUTICS, INC. /DE/.
Set alerts for John Poyhonen and 40,000+ other insiders.